Dolby Laboratories awarded Whitten Marc 160,256 shares and 600,000 derivative securities on 2026-09-15, with each award representing about 100.0% of the corresponding resulting holding. For investors, the transaction identifies the reported size and post-award ownership of both asset categories.
Key Highlights
- Whitten Marc’s share award represented about 100.0% of his resulting share holding.
- Dolby Laboratories recorded 600,000 derivative securities awarded to its President and CEO.
- Both transactions used SEC transaction code A, which denotes an award or grant.
Dolby Laboratories (NYSE: DLB) awarded Whitten Marc 160,256 shares on 15 September 2026, together with 600,000 derivative securities.
Dolby Laboratories Awards Shares and Derivative Securities
The two transactions were recorded separately by asset category, distinguishing the share award from the derivative-securities award. The share transaction accounted for about 100.0% of Whitten Marc’s resulting share holding. Dolby Laboratories therefore reported post-transaction ownership of 160,256 shares and 600,000 derivative securities across the two categories. The reported awards were made on the same date, 15 September 2026.
FAQs
Q: How many Dolby Laboratories shares did Whitten Marc receive?
A: Whitten Marc received 160,256 Dolby Laboratories shares on 15 September 2026. His reported resulting holding in that share category was also 160,256.
Q: How many derivative securities did Whitten Marc receive from Dolby Laboratories?
A: Whitten Marc received 600,000 Dolby Laboratories derivative securities. His resulting holding in that category was reported as 600,000 derivative securities.
Q: What does transaction code A mean in Whitten Marc’s Dolby Laboratories transaction?
A: SEC transaction code A identifies an award or grant. The code applied to both the 160,256-share transaction and the 600,000 derivative-securities transaction.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.